A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib
Clinical trial NCT03823378 · TERMINATED
Trial details
- NCT number
- NCT03823378
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2020-09-09
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.